IMPACT THERAPEUTICS
IMPACT Therapeutics is dedicated to the development of similar drugs to treat cancer have independent intellectual property rights and other diseases of the best (best-in-class) of new drugs and its commercialization. The company's senior management team of experienced and professional background complementary and have accumulated more than four decades of experience in drug development and management. General Manager and Chief Scientific Officer Field are an expert in pharmacology and biology.
IMPACT THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2009-06-01
Address:
Nanjing, Jiangsu, China
Country:
China
Website Url:
http://www.impacttherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+02558619059
Total Funding:
90 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content Nginx Euro PHP DigiCert SSL
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Asieris Pharmaceuticals
Asieris Pharmaceuticals is a Chinese biotech company.
CellGenTech
CellGenTech is a Therapeutics Company
Cerebral Therapeutics
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Haizhi Wangju Internet Technology
Haizhi Wangju Internet Technology is a china based company.
Luqa Pharmaceuticals
Luqa Pharmaceuticals is a China-focused company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Tian Tian Express
Tian Tian Express is Hangzhou based company.
Current Employees Featured
Investors List
Exome Asset Management
Exome Asset Management investment in Series D - IMPACT Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series D - IMPACT Therapeutics
CCBT Private Equity
CCBT Private Equity investment in Series D - IMPACT Therapeutics
Bestride
Bestride investment in Series D - IMPACT Therapeutics
Yuexiu Group
Yuexiu Group investment in Series D - IMPACT Therapeutics
Dingxin Capital
Dingxin Capital investment in Series D - IMPACT Therapeutics
China Summit Capital
China Summit Capital investment in Series D - IMPACT Therapeutics
Sam Isaly
Sam Isaly investment in Series D - IMPACT Therapeutics
C&D Emerging Investment
C&D Emerging Investment investment in Series D - IMPACT Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - IMPACT Therapeutics
Official Site Inspections
http://www.impacttherapeutics.com Semrush global rank: 6.99 M Semrush visits lastest month: 656
Unable to get host informations!!!
More informations about "IMPACT Therapeutics"
About Us - About Us - 英派 - IMPACT Therapeutics
Established and operated by an experienced management team in the pharmaceutical industry globally, the company has established a fully functional discovery and clinical development …See details»
英派 - IMPACT Therapeutics
IMPACT Therapeutics is a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality.See details»
IMPACT Therapeutics - Crunchbase Company Profile
IMPACT Therapeutics creates new treatments to treat cancer and other life-threatening disorders. The firm is committed to the discovery and development of targeted anti-cancer treatments based on synthetic lethality, hence offering …See details»
IMPACT Therapeutics, Inc. Overview | SignalHire Company Profile
IMPACT Therapeutics, Inc. is a private company that has been in the industry for 15 years. The company currently specializes in the Biotechnology, Pharmaceuticals areasSee details»
Impact Therapeutics - PharmaBoardroom
Apr 17, 2019 Funded by venture capital and based in China, IMPACT Therapeutics, Inc. (IMPACT) is dedicated to the discovery, development and commercialization of novel and …See details»
Impact Therapeutics Company Profile | Management and
[email protected]: Impact Therapeutics Top Competitors. Company Employees Revenue Top technologies; Intellectual Property Logium. 22: $4.5 M: Ipr Studio. 7: $1.4 M: …See details»
Impact Therapeutics | VentureRadar
Website: http://www.impacttherapeutics.com. Develops and discovers targeted anti-cancer therapeutics using synthetic lethality, focusing on global clinical ...See details»
IMPACT Therapeutics, Inc. (上海瑛派药业有限公司) - 药物管线_专 …
TPS3191 Background: PARP inhibitors (PARPi) selectively kill tumor cells harboring genetic mutations in critical DNA repair genes (e.g., BRCA1/2). While several approved nonselective …See details»
公司简介 - 关于英派 - 英派 - IMPACT Therapeutics
邮箱：[email protected] 地址：江苏省南京市江宁区秣陵街道景枫中心写字楼2506室 电话：025-52283667 邮箱：[email protected]See details»
Impact Therapeutics Inc. - BioCentury Company Profiles - BCIQ
Oct 18, 2023 Impact Therapeutics Inc. - BioCentury Company Profiles for the biopharma industrySee details»
IMPACT Therapeutics - Craft
IMPACT Therapeutics has 1 employees across 2 locations and $40 m in total funding,. See insights on IMPACT Therapeutics including office locations, competitors, revenue, financials, …See details»
Impact Therapeutics - Overview, News & Similar companies
Www.impacttherapeutics.com. Revenue $6.2 Million. Industry Pharmaceuticals Healthcare . Recent News & Media. Impact Therapeutics Entered into Global Partnership with Eik... Jun 1, …See details»
Impact Therapeutics | VentureRadar
Website: http://www.impacttherapeutics.com. Develops targeted anti-cancer therapeutics based on synthetic lethality, including multiple compounds and a novel ...See details»
Impact Therapeutics Announces Completion of Series D1 Financing
SHANGHAI, March 14, 2022 /PRNewswire/ -- IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics …See details»
Our Science - Our Science - 英派 - IMPACT Therapeutics
Email: [email protected] Address: Room 2506, Jingfeng Center, No. 1698 Shuanglong Avenue, Jiangning District, Nanjing TEL: 025-52283667 Email: …See details»
IMP 11 - AdisInsight
28 Apr 2020 IMP 11 is available for licensing as of 28 Apr 2020. www.impacttherapeutics.com 28 Apr 2020 IMPACT Therapeutics files for patent protection for its DDR inhibitors (including IMP …See details»
IMP 17 - AdisInsight - Springer
If your organization has a subscription, there are several access options, even while working remotely: Working within your organization’s network Login with username/password or try to …See details»
IMPACT Therapeutics and Genetron Health Announce Partnership …
Email: [email protected] Address: Room 2506, Jingfeng Center, No. 1698 Shuanglong Avenue, Jiangning District, Nanjing TEL: 025-52283667 Email: …See details»